Selected research
Industry Growth & Trends
Global Famotidine Industry Growth and Trends Forecast to 2032
Market perspective
The global Famotidine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Famotidine include UQUIFA, Rakshit Drug, Phalanx Labs, PAT IMPEX, Jayusion, Gauri Fine Chemicals, Darou Pakhsh Pharma Chem and Chempro Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Famotidine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Famotidine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Famotidine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Famotidine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Famotidine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Famotidine Market by Company
UQUIFA
Rakshit Drug
Phalanx Labs
PAT IMPEX
Jayusion
Gauri Fine Chemicals
Darou Pakhsh Pharma Chem
Chempro Pharma
Famotidine Segment by Type
Tablets
Injection
Famotidine Segment by Application
Hospital
Clinic
Other
Famotidine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famotidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Famotidine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famotidine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Famotidine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Famotidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injection
Applications
- Hospital
- Clinic
- Other
Companies covered
- UQUIFA
- Rakshit Drug
- Phalanx Labs
- PAT IMPEX
- Jayusion
- Gauri Fine Chemicals
- Darou Pakhsh Pharma Chem
- Chempro Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Famotidine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Famotidine Sales Estimates and Forecasts (2021-2032)
- 1.3 Famotidine Market by Type
- 1.3.1 Tablets
- 1.3.2 Injection
- 1.4 Global Famotidine Market Size by Type
- 1.4.1 Global Famotidine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Famotidine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Famotidine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Famotidine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Famotidine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Famotidine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Famotidine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Famotidine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Famotidine Industry Trends
- 2.2 Famotidine Industry Drivers
- 2.3 Famotidine Industry Opportunities and Challenges
- 2.4 Famotidine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Famotidine Revenue (2021-2026)
- 3.2 Global Top Players by Famotidine Sales (2021-2026)
- 3.3 Global Top Players by Famotidine Price (2021-2026)
- 3.4 Global Famotidine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Famotidine Major Company Production Sites & Headquarters
- 3.6 Global Famotidine Company, Product Type & Application
- 3.7 Global Famotidine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Famotidine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Famotidine Players Market Share by Revenue in 2025
- 3.8.3 2025 Famotidine Tier 1, Tier 2, and Tier 3
4 Famotidine Regional Status and Outlook
- 4.1 Global Famotidine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Famotidine Historic Market Size by Region
- 4.2.1 Global Famotidine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Famotidine Sales in Value by Region (2021-2026)
- 4.2.3 Global Famotidine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Famotidine Forecasted Market Size by Region
- 4.3.1 Global Famotidine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Famotidine Sales in Value by Region (2027-2032)
- 4.3.3 Global Famotidine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Famotidine by Application
- 5.1 Famotidine Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Famotidine Market Size by Application
- 5.2.1 Global Famotidine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Famotidine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Famotidine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Famotidine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Famotidine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Famotidine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Famotidine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Famotidine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 UQUIFA
- 6.1.1 UQUIFA Company Information
- 6.1.2 UQUIFA Business Overview
- 6.1.3 UQUIFA Famotidine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 UQUIFA Famotidine Product Portfolio
- 6.1.5 UQUIFA Recent Developments
- 6.2 Rakshit Drug
- 6.2.1 Rakshit Drug Company Information
- 6.2.2 Rakshit Drug Business Overview
- 6.2.3 Rakshit Drug Famotidine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Rakshit Drug Famotidine Product Portfolio
- 6.2.5 Rakshit Drug Recent Developments
- 6.3 Phalanx Labs
- 6.3.1 Phalanx Labs Company Information
- 6.3.2 Phalanx Labs Business Overview
- 6.3.3 Phalanx Labs Famotidine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Phalanx Labs Famotidine Product Portfolio
- 6.3.5 Phalanx Labs Recent Developments
- 6.4 PAT IMPEX
- 6.4.1 PAT IMPEX Company Information
- 6.4.2 PAT IMPEX Business Overview
- 6.4.3 PAT IMPEX Famotidine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 PAT IMPEX Famotidine Product Portfolio
- 6.4.5 PAT IMPEX Recent Developments
- 6.5 Jayusion
- 6.5.1 Jayusion Company Information
- 6.5.2 Jayusion Business Overview
- 6.5.3 Jayusion Famotidine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Jayusion Famotidine Product Portfolio
- 6.5.5 Jayusion Recent Developments
- 6.6 Gauri Fine Chemicals
- 6.6.1 Gauri Fine Chemicals Company Information
- 6.6.2 Gauri Fine Chemicals Business Overview
- 6.6.3 Gauri Fine Chemicals Famotidine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Gauri Fine Chemicals Famotidine Product Portfolio
- 6.6.5 Gauri Fine Chemicals Recent Developments
- 6.7 Darou Pakhsh Pharma Chem
- 6.7.1 Darou Pakhsh Pharma Chem Company Information
- 6.7.2 Darou Pakhsh Pharma Chem Business Overview
- 6.7.3 Darou Pakhsh Pharma Chem Famotidine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Darou Pakhsh Pharma Chem Famotidine Product Portfolio
- 6.7.5 Darou Pakhsh Pharma Chem Recent Developments
- 6.8 Chempro Pharma
- 6.8.1 Chempro Pharma Company Information
- 6.8.2 Chempro Pharma Business Overview
- 6.8.3 Chempro Pharma Famotidine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Chempro Pharma Famotidine Product Portfolio
- 6.8.5 Chempro Pharma Recent Developments
7 North America by Country
- 7.1 North America Famotidine Sales by Country
- 7.1.1 North America Famotidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Famotidine Sales by Country (2021-2026)
- 7.1.3 North America Famotidine Sales Forecast by Country (2027-2032)
- 7.2 North America Famotidine Market Size by Country
- 7.2.1 North America Famotidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Famotidine Market Size by Country (2021-2026)
- 7.2.3 North America Famotidine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Famotidine Sales by Country
- 8.1.1 Europe Famotidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Famotidine Sales by Country (2021-2026)
- 8.1.3 Europe Famotidine Sales Forecast by Country (2027-2032)
- 8.2 Europe Famotidine Market Size by Country
- 8.2.1 Europe Famotidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Famotidine Market Size by Country (2021-2026)
- 8.2.3 Europe Famotidine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Famotidine Sales by Country
- 9.1.1 Asia-Pacific Famotidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Famotidine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Famotidine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Famotidine Market Size by Country
- 9.2.1 Asia-Pacific Famotidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Famotidine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Famotidine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Famotidine Sales by Country
- 10.1.1 South America Famotidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Famotidine Sales by Country (2021-2026)
- 10.1.3 South America Famotidine Sales Forecast by Country (2027-2032)
- 10.2 South America Famotidine Market Size by Country
- 10.2.1 South America Famotidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Famotidine Market Size by Country (2021-2026)
- 10.2.3 South America Famotidine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Famotidine Sales by Country
- 11.1.1 Middle East and Africa Famotidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Famotidine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Famotidine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Famotidine Market Size by Country
- 11.2.1 Middle East and Africa Famotidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Famotidine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Famotidine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Famotidine Value Chain Analysis
- 12.1.1 Famotidine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Famotidine Production Mode & Process
- 12.2 Famotidine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Famotidine Distributors
- 12.2.3 Famotidine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst